Dragan Grabulovski obtained his PhD at ETH Zurich in the group of Prof Dario Neri. During his PhD studies he invented the Fynomer technology which was commercialized by Covagen. Prior to that, he studied pharmaceutical sciences at ETH Zurich and for the diploma thesis under the supervision of Prof Gerd Folkers he was awarded with the ETH medal. He is a co-author of several peer-reviewed articles, reviews, book chapters, poster abstracts, patent applications and granted patents (publication list). He is also a jury member of „venture“, Switzerland’s premier start-up competition organized by McKinsey, Innosuisse (Swiss commission for technology and innovation), EPFL and ETH Zurich.